文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

南非西开普省儿童使用EQ-5D-Y健康相关生活质量结果测量工具:心理测量特性、可行性和实用性——一项纵向分析研究

The use of the EQ-5D-Y health related quality of life outcome measure in children in the Western Cape, South Africa: psychometric properties, feasibility and usefulness - a longitudinal, analytical study.

作者信息

Scott Des, Ferguson Gillian D, Jelsma Jennifer

机构信息

Department of Health and Rehabilitation Sciences, Faculty of Health Sciences, University of Cape Town, Observatory 7925, Cape Town, South Africa.

出版信息

Health Qual Life Outcomes. 2017 Jan 19;15(1):12. doi: 10.1186/s12955-017-0590-3.


DOI:10.1186/s12955-017-0590-3
PMID:28103872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5248508/
Abstract

BACKGROUND: The EQ-5D-Y, an outcome measure of Health Related Quality of Life (HRQoL) in children, was developed by an international task team in 2010. The multinational feasibility, reliability and validity study which followed was undertaken with mainly healthy children. The aim of this study was to investigate the psychometric properties of the EQ-5D-Y when used to assess the HRQoL of children with different health states. METHOD: A sample of 224 children between eight and twelve years were grouped according to their health state. The groups included 52 acutely ill children, 67 children with either a chronic health condition or disability and 105 mostly healthy, mainstream school children as a comparator. They were assessed at baseline, at three months and at six months. An analysis of the psychometric properties was performed to assess the reliability, validity and responsiveness of the EQ-5D-Y in the different groups of children. Cohen's kappa, the intraclass correlation coefficient, Pearson Chi-square, Kruskal-Wallis ANOVA and effect size of Wilcoxon Signed-rank test were used to determine the reliability, validity and responsiveness of the instrument. RESULTS: The EQ-5D-Y dimensions were found to be reliable on test-retest (kappa varying from 0.365 to 0.653), except for the Usual Activities dimension (kappa 0.199). The Visual Analogue Scale (VAS) was also reliable (ICC = 0.77). Post-hoc analysis indicated that dimensions were able to discriminate between acutely ill and healthy children (all differences p < 0.001). The acutely ill children had the lowest ranked VAS (median 50, range 0-100), indicating worst HRQoL and was the only group significantly different from the other three groups (p < 0.001 in all cases). Convergent validity between all similar EQ-5D-Y and PedsQL, WeeFIM and Faces Pain Scale dimensions was only evident in the acutely ill children. As expected the largest treatment effect was also observed in these children (Wilcoxon Signed-rank test for VAS was 0.43). Six of the nine therapists who took part in the study, found the measure quick and easy to apply, used the information in the management of the child and would continue to use it in future. CONCLUSIONS: The EQ-5D-Y could be used with confidence as an outcome measure for acutely-ill children, but demonstrated poorer psychometric properties in children with no health condition or chronic conditions. It appears to be feasible and useful to include the EQ-5D-Y in routine assessments of children.

摘要

背景:儿童健康相关生活质量(HRQoL)的测评工具EQ-5D-Y由一个国际任务小组于2010年研发。随后开展的多国可行性、可靠性和有效性研究主要针对健康儿童。本研究旨在调查EQ-5D-Y用于评估不同健康状况儿童的HRQoL时的心理测量学特性。 方法:将224名8至12岁的儿童样本按健康状况分组。这些组包括52名急性病患儿、67名患有慢性健康问题或残疾的儿童以及105名大多健康的主流学校儿童作为对照。在基线、三个月和六个月时对他们进行评估。对心理测量学特性进行分析,以评估EQ-5D-Y在不同儿童组中的可靠性、有效性和反应性。使用科恩kappa系数、组内相关系数、皮尔逊卡方检验、克鲁斯卡尔-沃利斯方差分析和威尔科克森符号秩检验的效应大小来确定该工具的可靠性、有效性和反应性。 结果:发现EQ-5D-Y各维度在重测时具有可靠性(kappa系数在0.365至0.653之间),除了日常活动维度(kappa系数为0.199)。视觉模拟量表(VAS)也具有可靠性(组内相关系数ICC = 0.77)。事后分析表明,各维度能够区分急性病患儿和健康儿童(所有差异p < 0.001)。急性病患儿的VAS得分中位数最低(50,范围0 - 100),表明HRQoL最差,且是唯一与其他三组有显著差异的组(所有情况p < 0.001)。所有相似的EQ-5D-Y与儿童生活质量量表(PedsQL)、儿童功能独立性测量量表(WeeFIM)和面部疼痛量表维度之间的收敛效度仅在急性病患儿中明显。正如预期的那样,在这些儿童中也观察到了最大的治疗效果(VAS的威尔科克森符号秩检验为0.43)。参与研究的九名治疗师中有六名发现该测量方法快速且易于应用,在儿童管理中使用了该信息,并会在未来继续使用。 结论:EQ-5D-Y可以放心地用作急性病患儿的结局指标,但在无健康问题或慢性病患儿中显示出较差的心理测量学特性。将EQ-5D-Y纳入儿童常规评估似乎是可行且有用的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/5248508/06a0e77eadf8/12955_2017_590_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/5248508/32423f40f4a2/12955_2017_590_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/5248508/177e53034cf3/12955_2017_590_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/5248508/211a41b845d1/12955_2017_590_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/5248508/f450cac3bacf/12955_2017_590_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/5248508/8aad7401c4b1/12955_2017_590_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/5248508/3592bee684ed/12955_2017_590_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/5248508/75b558dfb08d/12955_2017_590_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/5248508/66fc6b3b2a66/12955_2017_590_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/5248508/06a0e77eadf8/12955_2017_590_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/5248508/32423f40f4a2/12955_2017_590_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/5248508/177e53034cf3/12955_2017_590_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/5248508/211a41b845d1/12955_2017_590_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/5248508/f450cac3bacf/12955_2017_590_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/5248508/8aad7401c4b1/12955_2017_590_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/5248508/3592bee684ed/12955_2017_590_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/5248508/75b558dfb08d/12955_2017_590_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/5248508/66fc6b3b2a66/12955_2017_590_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/5248508/06a0e77eadf8/12955_2017_590_Fig9_HTML.jpg

相似文献

[1]
The use of the EQ-5D-Y health related quality of life outcome measure in children in the Western Cape, South Africa: psychometric properties, feasibility and usefulness - a longitudinal, analytical study.

Health Qual Life Outcomes. 2017-1-19

[2]
How does the EQ-5D-Y Proxy version 1 perform in 3, 4 and 5-year-old children?

Health Qual Life Outcomes. 2020-5-24

[3]
Development of the web-based Spanish and Catalan versions of the Euroqol 5D-Y (EQ-5D-Y) and comparison of results with the paper version.

Health Qual Life Outcomes. 2015-6-3

[4]
Comparing the Psychometric Performance of Generic Paediatric Health-Related Quality of Life Instruments in Children and Adolescents with ADHD, Anxiety and/or Depression.

Pharmacoeconomics. 2024-6

[5]
The validity and reliability of the interviewer-administered EQ-5D-Y-3L version in young children.

Health Qual Life Outcomes. 2023-2-22

[6]
Psychometric Properties of the EQ-5D-Y-5L for Children With Intellectual Disability.

Value Health. 2024-6

[7]
EQ-5D-Y for the assessment of health-related quality of life among Taiwanese youth with mild-to-moderate chronic kidney disease.

Int J Qual Health Care. 2018-5-1

[8]
Measurement Properties of the Online EuroQol-5D-Youth Instrument in Children and Adolescents With Type 1 Diabetes Mellitus: Questionnaire Study.

J Med Internet Res. 2019-11-12

[9]
Psychometric Performance Comparison of the Adapted versus Original Versions of the EQ-5D-Y-3L and -Y-5L in Proxy Respondents for 2- to 4-Year-Olds.

Pharmacoeconomics. 2024-6

[10]
Validity and feasibility of the self-report EQ-5D-Y as a generic Health-Related Quality of Life outcome measure in children and adolescents with Juvenile Idiopathic Arthritis in Western Cape, South Africa.

S Afr J Physiother. 2019-7-30

引用本文的文献

[1]
Psychometric evaluation of the EQ-5D-Y-3L in Ethiopian pediatric inpatients: comparing self and proxy reports.

J Patient Rep Outcomes. 2025-8-13

[2]
Identifying candidate items for a health-related quality of life measure in young children with respiratory illness: A scoping review of generic and disease-specific measures.

PLoS One. 2025-5-5

[3]
Measurement Properties of the EQ-5D Instruments in Children and Adolescents: A Systematic Review.

Appl Health Econ Health Policy. 2025-4-19

[4]
How does a preference-based generic health-related quality of life measure perform in patients with a rare disease? Measurement properties of the EQ-5D-Y proxy version among underage patients with neurofibromatosis type 1.

Orphanet J Rare Dis. 2025-2-13

[5]
How do children understand and respond to the EQ-5D-Y-3L? A mixed methods study in a community-based sample of 6-12-year-olds.

Health Qual Life Outcomes. 2024-12-5

[6]
An item bank to measure health-related quality of life among young children (0-5-years-old) affected by respiratory illnesses - expert stakeholders and end-users from the Western Cape, South Africa.

Health Qual Life Outcomes. 2024-10-29

[7]
Transitioning between the EQ-5D youth and adult descriptive systems in a group of adolescents.

J Patient Rep Outcomes. 2024-8-12

[8]
The reliability and validity of the isixhosa version of the euroqol toddler and infant populations (EQ-TIPS) health related quality of life instrument.

Afr Health Sci. 2023-12

[9]
Measurement properties of the EQ-5D in children and adolescents: a systematic review protocol.

Syst Rev. 2024-1-5

[10]
Fighting to Breathe and Fighting for Health-Related Quality of Life: Measuring the Impact of Being Dependent on Technology for Breathing on the Child and Their Caregiver.

Patient. 2024-1

本文引用的文献

[1]
Prevalence and Losses in Quality-Adjusted Life Years of Child Health Conditions: A Burden of Disease Analysis.

Matern Child Health J. 2016-4

[2]
Valuation of Child Behavioral Problems from the Perspective of US Adults.

Med Decis Making. 2016-2

[3]
The Value Adults Place on Child Health and Functional Status.

Value Health. 2015-6

[4]
Development of the web-based Spanish and Catalan versions of the Euroqol 5D-Y (EQ-5D-Y) and comparison of results with the paper version.

Health Qual Life Outcomes. 2015-6-3

[5]
Valuation of Child Health-Related Quality of Life in the United States.

Health Econ. 2016-6

[6]
Adolescent self-report and parent proxy-report of health-related quality of life: an analysis of validity and reliability of PedsQL 4.0 among a sample of Malaysian adolescents and their parents.

Health Qual Life Outcomes. 2015-4-8

[7]
Measuring health-related quality of life with the EQ-5D-Y instrument in children and adolescents with asthma.

Acta Paediatr. 2015-2

[8]
Validation of the Chinese version of the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool (the CHO-KLAT).

Haemophilia. 2014-11

[9]
EQ-5D-Y as a health-related quality of life measure in children and adolescents with functional disability in Sweden: testing feasibility and validity.

Acta Paediatr. 2014-4

[10]
[Validity and reliability of the spanish EQ-5D-Y proxy version].

An Pediatr (Barc). 2014-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索